The Japanese Central Social Insurance Medical Council approved on Sept. 4 a new operational plan to ensure that unapproved off-label cancer drugs can come into use more quickly. The system, due to start in the second half of 2013, will involve external institutions which are entrusted to decide whether new drugs are to be used in advanced medical treatment, therefore speeding up the evaluation. External institutions must meet certain conditions regarding knowledge of cancer treatment. (Click Here For More – Japanese Language
Japan Central Social Insurance Medical Council To Entrust External Institutions For Advanced Evaluation Of Cancer Therapies
Japan’s Central Social Insurance Medical Council approved on Sept. 4 a new operational plan to ensure that unapproved off-label cancer drugs can come into use more quickly.